ConcertoCare Funding: $170M Raised, Series B (2022)
ConcertoCare is based in New York City, Country null. It has raised $170M in total funding. Latest round: Series B.
ConcertoCare funding overview
ConcertoCare is based in New York City, Country null. ConcertoCare has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2022. The round record for ConcertoCare runs through 2022; nothing later has been disclosed. Investors on record include Wells Fargo Strategic Capital, Obvious Ventures, Deerfield Management, AirAngels, Arkitekt Ventures, Benchmark and 18 others. 24 distinct backers are named across the disclosed rounds.
ConcertoCare has raised $170M in total disclosed funding across the rounds on record.
Who has invested in ConcertoCare?
Wells Fargo Strategic Capital, Obvious Ventures, Deerfield Management, AirAngels, Arkitekt Ventures, Benchmark are named among the investors backing ConcertoCare.
What was the latest ConcertoCare funding round?
The most recent disclosed round is a Series B, announced in February 2022.
Where is ConcertoCare based?
ConcertoCare is based in New York City, Country null.
When did ConcertoCare last raise?
The last disclosed ConcertoCare round closed in February 2022 at Series B.
Round data for ConcertoCare is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York City and backer lists below.
